Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union – författare

Visar alla böcker från författaren Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union.

1 produkt

Kategorier

1 produkt

Regulatory Processes for Rare Disease Drugs in the United States and European Union
Flexibilities and Collaborative Opportunities
Avand Medicine National Academies of Sciences, Engineering,Health and Medicine Divisionm. fl.
Häftad, Engelska, 2024
899 kr
Skickas inom 3-6 vardagar

Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union – författare

Visar alla böcker från författaren Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union.

1 produkt

Kategorier

1 produkt

Regulatory Processes for Rare Disease Drugs in the United States and European Union
Flexibilities and Collaborative Opportunities
Avand Medicine National Academies of Sciences, Engineering,Health and Medicine Divisionm. fl.
Häftad, Engelska, 2024
899 kr
Skickas inom 3-6 vardagar

Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union – författare

Regulatory Processes for Rare Disease Drugs in the United States and European Union

Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union – författare

Regulatory Processes for Rare Disease Drugs in the United States and European Union

Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union – författare

Regulatory Processes for Rare Disease Drugs in the United States and European Union

Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union – författare

Regulatory Processes for Rare Disease Drugs in the United States and European Union